Editorial

Roche's phase III IMmotion151 study of Tecentriq & Avastin to treat advanced/metastatic RCC meets co-primary endpoint

THE BRAND NAME ISSUE

  ,  
  ,  

NO FURTHER EXTENSION

  ,  

IMPLEMENT SOTS SCHEME

  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  

A FLAWED DECISION

  ,  
  ,  
  ,  
  ,  
  ,  
  ,  

REVISIT LICENSE TO PACS

  ,  

MONITOR THE MARKETERS

  ,  
  ,  

DEFINITION ON OTC DRUGS

  ,  

Results Found: 1366

Go to Total Number of Pages: 69
PharmaBiz News
Pharmaceuticals exports grew 2.37 per cent in April 2025
View More →
PharmaBiz News
Pharmaceuticals exports grew 2.37 per cent in April 2025
View More →